Sonnet BioTherapeutics Holdings, Inc.

Sonnet BioTherapeutics Holdings, Inc.verified

SONN

Price:

$1.6093

Market Cap:

$4.84M

Sonnet BioTherapeutics Holdings, Inc., a clinical stage oncology-focused biotechnology company, develops platform for biologic medicines of single or bispecific action. The company develops fully human albumin binding technology, which utilizes human single chain antibodies fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. Its lead candidate is SON-1010, a fully human version of interleukin 12 for the treatment non-small cell lung cancer, and head and neck cancer. The company is also developing SON-080, a fully human version of interleukin 6 for chemotherapy-induced peripheral neuropathy and diabetic peripheral neuropathy. It has a license agreeme...[Read more]

Industry

Biotechnology

IPO Date

2006-10-31

Stock Exchange

NASDAQ

Ticker

SONN

The ROE as of December 2024 (TTM) for Sonnet BioTherapeutics Holdings, Inc. (SONN) is -383.41%

According to Sonnet BioTherapeutics Holdings, Inc.’s latest financial reports and current stock price. The company's current ROE is -383.41%. This represents a change of -421.69% compared to the average of 119.18% of the last 4 quarters.

Sonnet BioTherapeutics Holdings, Inc. (SONN) Historical ROE (quarterly & annually)

How has SONN ROE performed in the past?

The mean historical ROE of Sonnet BioTherapeutics Holdings, Inc. over the last ten years is 979.15%. The current -383.41% ROE has changed -139.16% with respect to the historical average. Over the past ten years (40 quarters), SONN's ROE was at its highest in in the September 2023 quarter at 1.63%. The ROE was at its lowest in in the June 2020 quarter at -3101.22%.

Quarterly (TTM)
Annual

Average

979.15%

Median

-59.62%

Minimum

-1028.53%

Maximum

8.33%

Sonnet BioTherapeutics Holdings, Inc. (SONN) ROE by Quarter and Year

Discovering the peaks and valleys of Sonnet BioTherapeutics Holdings, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 610.58%

Maximum Annual ROE = 8.33%

Minimum Annual Increase = -Infinity%

Minimum Annual ROE = -1028.53%

Quarterly (TTM)
Annual
YearROEChange
20241.53%-81.63%
20238.33%610.58%
20221.17%-1144.01%
2021-112.34%-89.08%
2020-1028.53%-681.37%
2019176.91%-291.78%
2018-92.25%45.35%
2017-63.46%-10.35%
2016-70.79%26.91%
2015-55.78%-Infinity%

Sonnet BioTherapeutics Holdings, Inc. (SONN) Average ROE

How has SONN ROE performed in the past?

The current ROE of Sonnet BioTherapeutics Holdings, Inc. (SONN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

3.68%

5-year avg

1.98%

10-year avg

979.15%

Sonnet BioTherapeutics Holdings, Inc. (SONN) ROE vs. Peers

How is SONN’s ROE compared to its peers?

Sonnet BioTherapeutics Holdings, Inc.’s ROE is less than YS Biopharma Co., Ltd. (0%), greater than ZyVersa Therapeutics, Inc. (-77.30%), greater than Allarity Therapeutics, Inc. (-25512.50%), greater than Kiromic BioPharma, Inc. (-328.22%), less than Immix Biopharma, Inc. (327.18%), greater than CNS Pharmaceuticals, Inc. (-102.10%), less than eFFECTOR Therapeutics, Inc. (695.91%), less than Navidea Biopharmaceuticals, Inc. (2.18%), greater than null (-173.56%),

Build a custom stock screener for Sonnet BioTherapeutics Holdings, Inc. (SONN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sonnet BioTherapeutics Holdings, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sonnet BioTherapeutics Holdings, Inc. (SONN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sonnet BioTherapeutics Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Sonnet BioTherapeutics Holdings, Inc.'s ROE?

How is the ROE calculated for Sonnet BioTherapeutics Holdings, Inc. (SONN)?

What is the highest ROE for Sonnet BioTherapeutics Holdings, Inc. (SONN)?

What is the 3-year average ROE for Sonnet BioTherapeutics Holdings, Inc. (SONN)?

What is the 5-year average ROE for Sonnet BioTherapeutics Holdings, Inc. (SONN)?

How does the current ROE for Sonnet BioTherapeutics Holdings, Inc. (SONN) compare to its historical average?